Quick answer: Whether an instrument is single-use or reusable is set by the manufacturer's labelling, not by a clinic's budget sheet. In Canada, a health care setting must not internally reprocess a device that the manufacturer has labelled single-use, and a reusable device may only be reprocessed when the manufacturer supplies validated reprocessing instructions that the facility can actually follow. The cost comparison only becomes meaningful once reprocessing labour, consumables, validation and documentation are counted alongside the purchase price — the numbers most price lists leave out.
Most of the deciding evidence is produced at the cleaning bench, not at the purchasing screen. A facility that cannot clean to a verified, repeatable standard cannot justify reuse whatever the instrument costs, which is why a CliniEco 6 L benchtop ultrasonic cleaner with dual-frequency operation and an enzyme ultrasonic cleaning solution supplied as a 4 L concentrate sit at the start of almost every reuse decision in a Canadian practice. This article sets out what the rules actually require, builds the full cost of ownership for both options, gives a decision framework for which instruments suit reuse, and maps where the waste and environmental obligations land.
What do Canadian rules actually require?
Canadian practice is governed by provincial guidance and the standards those documents reference, not by a single federal rule. Public Health Ontario and the Provincial Infectious Diseases Advisory Committee, in their cleaning, disinfection and sterilization guidance for all health care settings (3rd edition, May 2013), set the position in plain language:
- Health care settings must not internally reprocess single-use medical equipment or devices.
- Critical and semi-critical devices labelled single-use must not be reprocessed and re-used unless reprocessing is done by a licensed reprocessor.
- As of that guidance, there were no licensed reprocessors in Canada; reprocessors licensed by the United States Food and Drug Administration operate in the United States.
The same document defines the terms that decide the argument. A reusable device is one the manufacturer allows, through the selection of materials and components, to be re-used. A single-use or disposable device is one the manufacturer has designated for single use only, and the guidance is explicit that such devices must not be reprocessed. A third category, single-patient use, may be re-used on the same patient but not on any other. Those three labels come from the manufacturer, and a facility cannot reclassify a device by deciding on its own that it looks sturdy enough.
There is a further obligation that is easy to miss: if a device cannot be cleaned and reprocessed to the recommended standard, the guidance says it should not be purchased in the first place, or should be designated single-use. Purchasing decisions are therefore part of the compliance record, not separate from it.
For Ontario dental offices, the Royal College of Dental Surgeons of Ontario sets out the same layering — the College's infection prevention and control standard, public health guidance, and the manufacturer's own reprocessing instructions, applied together. The College's standard is the minimum requirement dentists must meet in this area of practice; the manufacturer's instructions are the device-specific layer that sits underneath it.
How do the two options compare across the full cost of ownership?
Almost every published comparison of single-use and reusable instruments stops at unit price. That is the smallest part of the answer. The table below sets out the cost elements that decide the total, and which side of the ledger each one lands on.
| Cost element | Single-use instrument or pack | Reusable instrument | What actually drives it |
|---|---|---|---|
| Acquiring the device | Paid every time | Paid once, replaced on wear | Reusable items cost more per unit but spread over many uses |
| Decontamination labour | None | Every use, every instrument | The largest recurring line; scales with instrument count and staffing |
| Cleaning consumables | None | Every use | Enzymatic or neutral detergent, water, brushes, ultrasonic chemistry |
| Water and energy | None | Every use | Washer-disinfector or ultrasonic bath, rinse water quality |
| Packaging for the sterile barrier | Built into the pack | Every cycle | Pouches, reels or reusable wrap plus indicators |
| Sterilization utilities | None (unless re-terminally sterilized) | Every cycle | Steam, cycle time, chamber loading |
| Validation and monitoring | None | Ongoing | Process challenge devices, indicators, biological monitoring |
| Documentation and traceability | Minimal | Every cycle | Load logs, cycle parameters, release records, retention |
| Inspection and rejection | None | Every cycle | Holes, staining, wear, damaged hinges, failed seals |
| Waste stream | Contracted biomedical waste | Packaging waste plus eventual retirement | Waste disposal is priced by volume and stream, not by item count |
Read down that table and the shape of the decision becomes clear. A single-use item concentrates its cost at the moment of purchase; a reusable item moves the cost into labour, consumables, utilities and paperwork that recur on every cycle for the life of the instrument. Which side wins is a volume question, and it can only be answered with a facility's own load counts — not with a supplier's list price.
Two further economics matter and are frequently ignored. First, a reusable instrument has a finite life: reuse is only permitted within the limits the manufacturer states, and once those limits are reached the device must be retired and replaced, which restores a purchase cost that had been assumed away. Second, the fixed cost of a validated reprocessing cycle — the space, the equipment, the monitoring and the trained staff — exists whether the facility reprocesses ten instruments a week or a thousand. Facilities that already run a validated cycle for other reasons spread that fixed cost; a facility that would create a reprocessing line purely to avoid buying single-use items usually cannot.
Which instruments are suited to reuse? A decision framework
The question is not "should we use reusable instruments" but "for which devices, in which setting, can we evidence a validated reprocessing cycle". Work through the following in order; the first condition that applies decides the answer.
| Situation | Can it be reprocessed in-house? | Basis |
|---|---|---|
| Device labelled single-use by the manufacturer | No | Guidance is explicit that single-use devices must not be reprocessed internally |
| Critical device, reusable-labelled, with validated reprocessing instructions | Yes, when the cycle is validated | Manufacturer's instructions govern the method, materials and cycle limits |
| Semi-critical device, reusable-labelled | Yes, to the required level (high-level disinfection or sterilization) | Depends on the tissue the device contacts |
| Device with lumens, hinges or complex geometry | Yes, only with a cleaning method that reaches every surface and a verification step | Residual soil in a lumen defeats everything downstream |
| Single-patient-use device | Only on the same patient | Manufacturer's designation, not a facility choice |
| Needles, lancets, blades, glass | Never | Not safe to clean by hand, and a sharps hazard to the reprocessing worker |
| Device with no validated cleaning instructions, or that cannot be cleaned | No | Should not have been purchased; designate single-use |
| Device used on a patient with a confirmed prion disease | Do not standard-reprocess; follow the specific guidance | Standard steam cycles are not the accepted route for these instruments |
The framework has an important property: almost every "no" is a labelling or validation fact, not a budget judgement. That is what makes the decision defensible at inspection.
How long does a reusable instrument last, and when does it fail?
Reusable does not mean indefinite. Manufacturer's instructions define the number of reprocessing cycles and the conditions a device may withstand, and the practical limits show up as a set of traceable failure modes:
- Seals, gaskets and insulation on powered or hinged instruments wear and lose function before the metal shows any problem.
- Hinges and box joints accumulate soil that resists cleaning even when the exterior looks clean, and can seize.
- Cutting edges dull with reprocessing handling, not just with use, and a dull instrument changes clinical performance.
- Coatings and finishes chip, creating a surface that holds soil and cannot be cleaned to the required standard.
- Lumens narrow or become scored, making the cleaning verification step harder to satisfy over time.
The consequence for the cost model is straightforward: a reuse programme carries a replacement rate. Once that rate is included, the "free after purchase" assumption disappears, and the true comparison is single-use price against the sum of per-cycle reprocessing cost plus amortized replacement cost.
Where do waste and environmental obligations land?
Waste is where the two options diverge most sharply in the paperwork, and in Ontario the obligations are set by the province's waste rules and by the ministry's guideline for biomedical waste rather than by the sterilization standard.
Biomedical waste is one of the waste types regulated under Ontario's Environmental Protection Act; the ministry's guideline C-4 sets out the expectation for managing it, and it adds to the requirements of Regulation 347 (General – Waste Management) rather than replacing them. Reg 347 defines the statutory categories — including pathological waste and the storage conditions for sharps — while C-4 maps the generator's obligations onto containment, labelling and storage.
| Waste arising | How it is handled | Containment and label | Storage |
|---|---|---|---|
| Discarded sharps (needles, blades, laboratory glass) | Segregated at point of use | Single-use or reusable sharps container, yellow universal biohazard label | No refrigeration required |
| Cytotoxic sharps | Separate stream | Sharps container, red cytotoxic label | No refrigeration required |
| Human blood waste | Segregated from all other waste | Single-use or reusable container, yellow universal biohazard label | Refrigerate if stored more than 4 days |
| Human anatomical waste | Highest-segregation stream | Single-use container, red anatomical label | Refrigerated at all times |
| Cytotoxic waste (not commingled with sharps) | Separate stream | Single-use container, red cytotoxic label | No refrigeration required |
| Used single-use instrument, not sharps | Segregated as biomedical waste | According to the category it falls into | Per the category |
Two points follow. First, a single-use instrument does not simply disappear at the end of the procedure; it enters a regulated, colour-coded, contracted disposal stream with its own packaging, labelling and storage rules, and that stream is a recurring cost. Second, the same containment system accepts both single-use and reusable containers in several categories, so the choice between the two is a container decision as well as an instrument decision.
The environmental side of the trade-off is genuine in both directions and should be described honestly rather than resolved by slogan. Single-use instruments and their packaging generate biomedical and general waste that must be handled, transported and treated. Reusable instruments eliminate that waste per use but consume water, energy and chemical detergent on every cycle, and produce a different waste stream — the packaging from each cycle, plus the instruments and containers at end of life. A facility choosing between the two is choosing which burden it can measure and manage, and both burdens are real.
What do other jurisdictions do about single-use reprocessing?
The contrast is instructive because it shows that the Canadian position is a regulatory choice, not a technical impossibility. The CDC's guideline for disinfection and sterilization in healthcare facilities (2008, page content updated June 2024) records that reuse of single-use devices began in the late 1970s, that most devices had previously been treated as reusable, and that reuse grew as a cost-saving measure — with roughly 20 to 30 per cent of United States hospitals reporting that they reuse at least one type of single-use device. Reuse, in other words, is not rare where a licensed reprocessing industry exists.
Canada's guidance points to a narrower arrangement. Devices labelled single-use are not to be reprocessed in-house, and where a facility wants that work done it should be performed by a licensed reprocessor whose facilities and procedures have been certified by a regulatory authority or an accredited quality system auditor. The same passage sets out what a facility contracting that work must be able to do: track and label the devices, recall improperly reprocessed items, hold proof of sterility or high-level disinfection, test for pyrogens, maintain device function and integrity, run quality assurance and control, report adverse events, and operate to good manufacturing procedures. Those requirements are the reason the model is not simply "send it away to be cleaned": the sending facility still carries the traceability obligation.
Health Canada has also addressed the general principle in a published notice on reprocessing respirators, noting that reprocessing devices intended for single use only is not a new concept and had been done successfully with other devices used in Canada. The notice makes the dependency explicit: for a device to be reprocessed, evidence that reprocessing works for that specific device has to exist. That is the same thread running through the provincial guidance — the labelling and the evidence, not the price, decide what may be reused.
For a Canadian clinic, the practical reading is that single-use reprocessing is a documented, regulated activity with a licensing gate, not a way to stretch a consumable budget quietly.
Should every facility run the same answer?
No. The decision is device-level and facility-level together, and the correct output of this analysis is not a slogan in either direction. A small clinic that sterilizes a few dozen loads a week and has no washer-disinfector is unlikely to build a reuse programme for the sake of it. A larger facility that already runs a validated reprocessing cycle, with trained staff, monitored equipment and complete records, has already paid the fixed cost and can extend it. A mixed model is normal and defensible — single-use for devices that cannot be cleaned to standard or that present a sharps hazard, reusable for instruments the manufacturer has validated for it.
What makes any of those positions hold up is the same three things: the manufacturer's labelling on the device, the validated reprocessing instructions, and the records that show the facility followed them. Get those right and the cost comparison is a business decision. Get them wrong and the cost comparison is beside the point.
Sources
- Public Health Ontario / PIDAC — Cleaning, Disinfection and Sterilization in All Health Care Settings, 3rd edition (May 2013), Appendix C and Section 2.P
- Ontario Ministry of the Environment, Conservation and Parks — Guideline C-4: The management of biomedical waste in Ontario
- Ontario Regulation 347 — General – Waste Management (Environmental Protection Act)
- Ontario Regulation 67/93 — Health Care and Residential Facilities (Occupational Health and Safety Act)
- Royal College of Dental Surgeons of Ontario — Infection Prevention and Control standard
- Royal College of Dental Surgeons of Ontario — Standard of Practice: Infection Prevention and Control in the Dental Office, v3
- CDC — Guideline for Disinfection and Sterilization in Healthcare Facilities (2008, updated June 2024)
- Health Canada — Reprocessing of N95 respirators notice (Open Government dataset record)
- Canadian Centre for Occupational Health and Safety — occupational health and safety resources
- CSA Group — Effective sterilization in health care facilities by the steam process (CSA Z314.3)
- ISO — ISO 11607-1, packaging for terminally sterilized medical devices
- CliniEco Medical — sterilization monitoring collection
Put the decision on paper before you change anything
- Take the paperwork side with you. The sterilization record centre carries a printable blank log sheet and a load-log generator, arranged as four record groups that line up with the RCDSO IPAC self-audit form, and it runs in the browser without an account.
- Count your own volumes first. The same page includes a self-check you can run against your current load counts, so a facility can see how many cycles a week it actually processes before changing how instruments are supplied.
- Have a question about your own facility? Send it in and you will get a written answer specific to your setup, with the regulation or standard it is based on cited. Ask your compliance question.
- Ordering for a clinic, a lab or a care home? Wholesale and multi-site ordering covers case pricing and account setup, and the B2B wholesale collection lists the lines stocked for institutional buyers.
- become a distributor
Related reading
- Spore test schedules: how often to run a biological indicator
- Reusable wrap vs single-use pouches: the packaging cost question
- Can single-use cartridges be reused? A straight answer
- Biomedical waste segregation: colour bags and sharps containers in Canada
Frequently Asked Questions
Can a Canadian clinic reprocess a device the manufacturer has labelled single-use?
No. Health care settings must not internally reprocess single-use medical equipment or devices, and critical or semi-critical devices labelled single-use must not be reprocessed and re-used unless the work is done by a licensed reprocessor. At the time of the Ontario guidance, there were no licensed reprocessors in Canada.
Is a reusable instrument always less expensive than a single-use one?
Not automatically. Reusable instruments remove the repeat purchase cost but add decontamination labour, cleaning consumables, water and energy, packaging, monitoring, records and inspection on every cycle. They also have a finite life and a replacement cost. The comparison turns on the facility's actual loading volume, not on the unit price of either option.
Which instruments can never be reprocessed?
Devices the manufacturer has designated single-use, needles, lancets, blades, laboratory glass, and any device that cannot be cleaned to the recommended standard can never be safely reprocessed in a health care setting. Devices used on a patient with confirmed prion disease follow a separate, specific route rather than the standard cycle.
Does the manufacturer's labelling or the province's guidance take precedence?
They operate together rather than in competition. Provincial guidance sets the baseline duty, and the manufacturer's instructions define the device-specific method, materials and cycle limits. A facility has to satisfy both, and where the manufacturer has supplied no validated reprocessing instructions, the device cannot be reprocessed to standard.
Where does a used single-use instrument go?
Into the biomedical waste stream, segregated from ordinary waste at the point of generation and placed in the container and label the waste category requires. Sharps go into a puncture-resistant sharps container at point of use; blood waste and anatomical waste carry different container colours and labelling, and some categories must be refrigerated.
What records does a reuse programme have to keep?
Enough to show that each instrument was cleaned and reprocessed to the validated method: the cleaning and sterilization records for the cycle, the monitoring results that released the load, and traceability that links the instrument to the cycle. Where a third-party reprocessor is used, the facility must still be able to track, label and recall the devices it sent.
CliniEco Medical supplies sterilization monitoring and reprocessing consumables in Canada. MDEL #35334.
0 comments